Barclays’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
130,911
+53,362
| +69% | +$530K | ﹤0.01% | 2492 |
|
|
2025
Q1 | $736K | Sell |
77,549
-12,101
| -13% | -$115K | ﹤0.01% | 2617 |
|
|
2024
Q4 | $1.24M | Buy |
89,650
+53,354
| +147% | +$737K | ﹤0.01% | 2503 |
|
|
2024
Q3 | $552K | Buy |
36,296
+18,724
| +107% | +$285K | ﹤0.01% | 2935 |
|
|
2024
Q2 | $85K | Buy |
+17,572
| New | +$85K | ﹤0.01% | 3449 |
|
|
2021
Q4 | – | Sell |
-6,330
| Closed | -$25K | – | 3301 |
|
|
2021
Q3 | $25K | Buy |
6,330
+4,501
| +246% | +$17.8K | ﹤0.01% | 3574 |
|
|
2021
Q2 | $9K | Buy |
1,829
+1,731
| +1,766% | +$8.52K | ﹤0.01% | 3890 |
|
|
2021
Q1 | $0 | Buy |
+98
| New | – | ﹤0.01% | 3906 |
|